Job Type

Full-time

Full Job Description

The Role:

This position is based in the Translational Biology team in the Biological Science Department will involve design and implementation of gene editing strategies (CRISPR) for profiling of novel models that help bridge the in vitro to in vivo translation. Functional characterization in cells and in silico analysis to determine gene perturbation after genome editing

Molecular biology, Biology, Molecular Medicine, Biochemistry or closely related fields majors are encouraged to apply.

Here’s What You’ll Do:

• Design and implement multiple technologies involving precise genome editing, gene delivery, protein engineering and stem cell technologies.

• Maintain cell lines and perform cell culture work

• Implement functional characterization of gene modified or edited cells lines

• In silico analysis of genetic perturbation after genome editing.

• Keep a good record of results, summarize and present results.

• Provide input and participate in team/department meetings.

Here’s What You’ll Bring to the Table:

• Minimum GPA of 3.4.

• Currently enrolled Junior or Senior.

• Previous co-op or intern experience preferred.

• Previous exposure to molecular biology, cell biology, cell culture is preferred.

• Must be curious, motivated, open to learning, and independent .

Here’s What We’ll Bring to the Table:

• On-site subsidized cafeteria or catered lunches
• Free parking, monthly subway pass or a subsidized commuter rail pass
• Free annual corporate membership to Bluebikes
• Highly competitive healthcare coverage including: medical offered through BCBS (HMO/PPO), dental, and vision offered through VSP
• Flexible Spending Accounts for medical expenses and dependent care expenses

About Moderna :

In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the promising-but-still-unproven field of messenger RNA (mRNA), to an enterprise with its first medicine having treated millions of people, a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.

Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 13 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com .

Moderna is a smoke-free, alcohol-free and drug-free work environment.

Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.